Romano Brothers AND Company Has $572,000 Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Romano Brothers AND Company decreased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 63.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 26,380 shares of the pharmacy operator’s stock after selling 46,662 shares during the quarter. Romano Brothers AND Company’s holdings in Walgreens Boots Alliance were worth $572,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in Walgreens Boots Alliance by 14.5% in the 3rd quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after purchasing an additional 10,962,030 shares during the last quarter. Capital World Investors lifted its stake in shares of Walgreens Boots Alliance by 29.1% in the 4th quarter. Capital World Investors now owns 18,448,648 shares of the pharmacy operator’s stock valued at $481,694,000 after acquiring an additional 4,163,317 shares during the last quarter. Morgan Stanley boosted its holdings in shares of Walgreens Boots Alliance by 15.8% during the 3rd quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock valued at $279,876,000 after acquiring an additional 1,720,228 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in Walgreens Boots Alliance by 10.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 6,519,845 shares of the pharmacy operator’s stock worth $170,233,000 after acquiring an additional 613,847 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. increased its holdings in Walgreens Boots Alliance by 12.4% in the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 3,077,336 shares of the pharmacy operator’s stock worth $80,349,000 after purchasing an additional 339,143 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

Insider Transactions at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari acquired 3,000 shares of the firm’s stock in a transaction dated Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CFO Manmohan Mahajan purchased 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the firm’s stock in a transaction on Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. SVB Leerink reduced their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a report on Monday, March 18th. TD Cowen reduced their target price on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, April 3rd. Barclays decreased their price target on shares of Walgreens Boots Alliance from $21.00 to $19.00 and set an “underweight” rating for the company in a research report on Monday, June 24th. Evercore ISI cut their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a report on Friday. Finally, Truist Financial decreased their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a report on Friday. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $20.64.

Walgreens Boots Alliance Stock Performance

Shares of Walgreens Boots Alliance stock opened at $12.10 on Friday. The stock’s 50-day moving average is $16.49 and its 200 day moving average is $20.17. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.32 and a current ratio of 0.65. Walgreens Boots Alliance, Inc. has a one year low of $11.68 and a one year high of $31.32.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing the consensus estimate of $0.67 by ($0.04). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The company had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. During the same period last year, the business earned $1.00 EPS. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. As a group, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.94 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 annualized dividend and a dividend yield of 8.27%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.